News Choose Year All Years 2026 (2) 2025 (6) 2024 (6) 2023 (2) 2022 (2) 2021 (1) Search Press Releases Found 19 Results May 27, 2026 Rectify Pharmaceuticals Presents New Translational Data at EASL 2026 Supporting RTY-406, its Clinical Candidate for the Treatment of Primary Sclerosing Cholangitis Read More May 13, 2026 Rectify Pharmaceuticals to Present Preclinical Data on New Dual Targeted ABCB4/BSEP Positive Functional Modulator at EASL 2026 Read More December 22, 2025 Rectify and Boehringer Ingelheim Collaborate to Advance First-in-class Treatments for Chronic Kidney Disease Read More June 6, 2025 Rectify Pharma Presents Translational Data Demonstrating Improvements in Kidney Function and Reductions in Vascular Calcification at ERA 2025 Read More May 21, 2025 Rectify Pharma to Present Translational Data on Novel Approach to Treat Chronic Kidney Disease and Vascular Calcification at ERA 2025 Read More May 9, 2025 Rectify Pharma Presents Translational Data for Novel Positive Functional Modulator Demonstrating Improved Biliary and Liver Health at EASL 2025 Read More April 23, 2025 Rectify Pharma to Share Preclinical Data Highlighting Progress in Hepatobiliary Program at EASL 2025 Read More April 7, 2025 Rectify Pharma Announces Publication of BSEP Transporter Biophysical Characterization in Communications Biology Read More 123»
Read More